Fusion Pharmaceuticals Inc

NASDAQ: FUSN
$21.40
-$0.02 (-0.1%)
Closing price May 7, 2024

FUSN Chart and Intraday Price

FUSN Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 270 LONGWOOD ROAD SOUTH, HAMILTON, ON, CA
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 868.15M USD
Shares Outstanding 72,406,000
Fusion Pharmaceuticals Inc is a pioneering force in the field of oncology, focusing on the development of radiopharmaceuticals as targeted cancer treatments. With operations in Canada and the United States, the company's innovative approach is exemplified by its leading product candidates, including FPI-2265 for prostate cancer and FPI-1434 for various solid tumors. Beyond its clinical trials, Fusion Pharmaceuticals is exploring potential cancer therapies in collaboration with AstraZeneca, aiming to revolutionize cancer treatment through precision medicine. Founded in 2014 and based in Hamilton, Canada, Fusion is at the forefront of combating cancer with cutting-edge science.

FUSN Articles

2 Red-Hot Stocks Highlight Wednesday's Top Wall Street Upgrades and Downgrades
A quiet week so far with markets trading slightly higher and analyst ratings trickling in. Just enough action to keep investors interested.
Lee Jackson, Paul Ausick
Published: